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Abstract 
 
 
Adult newt retinal pigment epithelium (RPE) cells are reprogrammed into a unique state of 
multipotent cells at an early phase of retinal regeneration. Here, to understand the signal 
triggering of reprogramming, four classes (v1, v2, v3 and v4) of Pax6 variants in the eyes of 
adult newt were identified and their expression in RPE cells after retinectomy was investigated. 
The Pax6 v1 and v2 variants were newly expressed in RPE cells by 10 days after retinectomy, 
both in vivo and in vitro. In vitro examinations suggested that Pax6 expression is mediated 
through a pathway separate from the MEK-ERK pathway, which is required for cell cycle 
re-entry of RPE cells, but in a condition closer to the in vivo state, it was promoted by the 
activity of MEK. These findings predict the existence of a pathway that must be further pursued 
to understand the reprogramming of RPE cells during retinal regeneration. 
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1. Introduction 
 
 
1.1. The RPE cells 
Retina pigment epithelium (RPE) is a simple epithelium constituting the eyeballs of vertebrates. 
RPE surrounds the back of the neural retina (NR), which receives light. This tissue adheres to the 
basement membrane, which is located external to it, and the choroid membrane, whose blood vessels 
are distributed external to it. RPE tissue is comprised of one kind of single-layered epithelium cells 
named RPE cells. These cells, which accumulate melanin and have microvilli, play essential roles in 
early visual processing as a partner of the NR. Mature RPE cells do not divide and specialize 
morphologically and functionally (for reviews, see Fuhrmann et al., 2014; Strauss, 2005). 
However, when the NR suffers from a traumatic injury, RPE cells lose their epithelial 
characteristics and undergo proliferation and transformation. As an example, there is proliferative 
vitreoretinopathy (PVR), which is a human disease. When RPE cells are exposed to serum, causing 
the detachment of retina and colloidal disorder, they can be isolated from the basement membrane 
and lose their epithelial structure. Moreover, these cells migrate into the vitreous through tears in the 
neural retina. Then, they form an epiretinal membrane on the surface of the NR, leading to the loss 
of vision. This process is a kind of epithelial-mesenchymal transition (EMT), a phenomenon in 
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which the epithelial cells detach from the underlying basement membrane and tranform into 
mesenchymal cells which involves enhanced migratory capacity and the production of extracellular 
matrix components (Chiba, 2014). 
 
1.2. Newt RPE cells contribute to neural regeneration 
On the other hand, in the newt, a group of the family Salamandridae in urodele amphibians, a similar 
change in RPE cells enables them to regenerate an entire retina, even as adults (Chiba et al., 2006a; 
Chiba and Mitashov, 2007; Chiba, 2014). In the adult newt, when the NR is completely removed 
from the eye by a surgical operation ‘retinectomy’ (Figure 1A,B), RPE cells are detached from each 
other as well as from the basement membrane, losing their epithelial characteristics to become cell 
aggregates, while reaching the S-phase of the cell-cycle (Figure 1C). Ten days after an operation, 
when these changes are observed, is defined as Stage ‘E-1’. These RPE-derived cells are then sorted 
into two populations which form the prospective-NR and -RPE layers (pro-NR and pro-RPE layers, 
respectively) with correct polarity (Figure 1D). Cells in the pro-NR and pro-RPE layers start to 
proliferate and eventually regenerate new functional NR and RPE (Figure 1E). Therefore, newt 
retinal regeneration serves as a good model system to compare with RPE-mediated retinal disorders 
in humans, providing insight into medical treatments that would allow for in vivo retinal 
regeneration (Chiba, 2014). 
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1.3. The reprogramming of RPE cells 
What changes occur to newt RPE cells that have lost their epithelium form? Recently, our 
laboratory has isolated RPE cells before retinectomy and at Stage E-1, and compared their gene 
expression profiles. This study demonstrated that RPE cells at Stage E-1 express three pluripotency 
factors, i.e., c-Myc, Klf4 and Sox2, as well as factors involved in fate switching between the NR and 
RPE in embryonic/larval stages, namely Pax6 and Mitf (Islam et al., 2014). Since these genes have 
not been confirmed as intact RPE cells, it is thought that they express newly in the process of 
regeneration. On the other hand, RPE cells at Stage E-1 preserve certain original characteristics such 
as the presence of microvilli and the expression of RPE65, which is an RPE cell-specific marker 
(Islam et al., 2014). Adult newt RPE cells are then reprogrammed into a unique multipotent state 
which has the potential to create neural retinas and is observed only in the regeneration process. The 
cells of this state are referred to as RPE stem cells (RPESCs). However, it remains uncertain what 
signals trigger the reprogramming of RPE cells as well as cell cycle re-entry. 
 
1.4. Pax6 is expressed in RPESCs 
In this study, this subject was attempted to approach by focusing on the expression of transcription 
factor Pax6. Pax6 is a well-known master control gene of eye morphogenesis and a highly conserved 
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transcription factor. It is a protein that is essential to the normal development of the retina from 
Drosophila melanogaster to humans (Baumer et al., 2002). In vertebrate development, Pax6 exists 
over a wide area, including the retina and RPE progenitor cells, at the early optic cup stage. During 
cell differentiation, Pax6 expression is limited and finally disappears in the mature RPE and neural 
retina except for amacrine, horizontal and ganglion cells (Davis-Silberman et al., 2005; Hsieh et al., 
2009; Macdonald et al., 1997). 
In the study of newt regeneration, it has been suggested that Pax6 is expressed in the eyeball of 
Stage E-1. Furthermore, the Pax6 sequence was elucidated when genetic information about the newt 
was poor and Pax6 was the rare protein that an antibody equivalent was available. Expression of 
Pax6 in reprogramed cells was also confirmed in a recent study using isolated RPE cells. It is 
thought that Pax6 mRNA expresses in all RPESCs of Stage E-1, and after two cell layers have arisen 
from RPESCs, pro-NR cells gradually change in Pax6-positive cells, as confirmed by 
immunohistochemistry (Islam et al., 2014). Therefore, Pax6 is a useful marker to trace the process of 
reprogramming in RPE cells. 
 
1.5. Pax6 structure and variety 
In studies involving Pax6, it is necessary to consider the function of multiple transcription products. 
Pax6 variants are derived from a difference in the transcription initiation site on the same locus, and 
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consist of many isoforms generated via post-transcriptional regulation such as alternative splicing. 
Several Pax6 variants with different structures have been reported (Bandah et al., 2007; Gorlov and 
Saunders, 2002; Kammandel et al., 1999; Kim and Lauderdale, 2006; Shaham et al., 2012; Short and 
Holland, 2008). 
The first variant, named “canonical Pax6”, is the most universal and abundant of the Pax6 variants 
(Figure 2). This variant includes two DNA-binding paired-domain (PD) and homeo-domain (HD) in 
the N-terminal region. These two domains are separated by glycine-rich linker. The C-terminal 
region of Pax6 is enriched with proline, serine and threonine (PST) residues (Shaham et al., 2012). 
The PD consists of two subdomains named PAI and RED. PAI and the RED subdomain have an 
HTH motif each (Xu et al., 1995; Xu et al., 1999; Epstein et al., 1994a). The C-terminal region of 
Pax6 is enriched with PSTs and functions as a transcriptional transactivator (Czerny and Busslinger, 
1995; Tang et al., 1998). These structures are widely conserved from flies to humans (Xu et al., 
1995; Xu et al., 1999). 
Secondly, in vertebrates, there is a Pax6(5a) variant that is made by post-transcriptional alternative 
splicing that inserts an additional exon 5a into canonical Pax6 (Figure 2; Walther and Gruss, 1991). 
Since the insertion site is the HTH motif in PAI, PAI loses its DNA binding capacity while that of 
RED is maintained (Epstein et al., 1994b). As a result, the DNA-recognition sequence of Pax6(5a) is 
different from canonical Pax6 (Epstein et al., 1994b). Different proportions of canonical Pax6 and 
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Pax6(5a) express in each tissue, and changes in their ratio cause pathological conditions and 
abrogated development (Epstein et al., 1994b; Pinson et al., 2005; Zhang et al., 2001). 
 The third Pax6 variant, which lacks the PD and is termed paired-less, is made by a promoter 
unlike canonical Pax6 and Pax6(5a) in vertebrates (Figure 2). The overexpression of this variant 
disturbs the development of the cornea and lens, and causes the microphthalmic phenotype (Kim and 
Lauderdale, 2006, 2008). However, its physiological activity in the eye is still unknown (Shaham et 
al., 2012). 
 In addition, many Pax6 variants have been reported. For example, in the PST region of amphibian 
and mouse Pax6, it has been reported that a part equivalent to exon 12 of human Pax6 is spliced out 
and subsequently shifts the sequence (Mizuno et al., 1997). A functional analysis of the majority of 
these variants has not been performed. 
 
1.6. The newt Pax6 
In the newt, two kinds of Pax6 splicing, namely the addition of a PD and the deletion of part of the 
PST, were discovered. Four kinds of variants (LL, LS, SL and SS) form from different combinations 
of this splicing. SL and LL are homologs of canonical Pax6 and Pax6(5a), respectively. SS and LS 
are variants in which the exon in the PST splices out from SL and LL (Mizuno et al., 1997). 
However, the paired-less variant has not been found and knowledge about Pax6 variants of the newt 
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is limited. In addition, there are few reports related to the expression and function of known Pax6 
variants. Our previous study demonstrated that canonical Pax6 is newly expressed in RPESCs. 
However, it remains unknown which other variants are expressed in those cells. 
Therefore, in the first part of this study, utilizing a transcriptome database IMORI 
(http://antler.is.utsunomiya-u.ac.jp/imori/), which our laboratory established to study newt retinal 
regeneration (Nakamura et al., 2014), Pax6 variants expressed in the adult newt eye were attempted 
to thoroughly identify. Then, in the second part of this study, on the basis of this information, the 
Pax6 classes that are expressed in RPE cells upon retinectomy were explored. Finally, the pathways 
that triggered Pax6 expression were investigated. 
 
1.7. The RLEC system 
In newt retinal regeneration, it is challenging to study the molecular mechanism underlying the 
reprogramming of RPE cells through injection/implantation of chemical tools into the eye because i) 
the wound along the dorsal half of the eye, from which the NR is removed, has not closed until ~2 
weeks in which reprogramming has been completed; ii) since RPE cells become solitary upon 
retinectomy and are then distributed in the vitreous cavity, the microenvironment (or niche) 
surrounding RPE cells is susceptible to physical perturbations, resulting in the abnormal 
regeneration of retinas, mostly giving rise to rosette-shaped tissues, even when using normal saline 
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only; iii) more essentially, the wound/injury itself, which is inevitably made for retinectomy or 
chemical treatments, may turn-on reprogramming signals. In this study, candidate pathways were 
attempted to identify by using the retina-less eye-cup (RLEC) system, an in vitro system which our 
laboratory has introduced to study the initial response of RPE cells in association with the wounding 
of eyes and retinectomy (Yohikawa et al., 2012). In this system, almost the same operation of 
retinectomy as that made in vivo was carried out in vitro. This ensured that the posterior half of the 
eyeball is missing the NR (i.e., the RLEC), which is then incubated in a minimal essential medium. 
In this condition, RPE cells do not appear to have died or have been seriously altered for as long as 
10 days. In fact, when RPE-choroid tissues isolated on day-10 are implanted into the vitreous cavity 
of the eye of a living animal immediately after retinectomy, retinal tissue is regenerated from the 
implanted RPE (also see Chiba et al., 2006b). However, it is unknown whether the RLEC system can 
be used as a tool to check the signal(s) causing the reprogramming of RPE cells. After the style of 
Pax6 expression in the RLEC system and RPESCs were compared, and confirmed whether in vitro 
Pax6 expression reflects real regeneration, it was necessary to examine the factor(s) participating in 
the reprogramming of RPE cells. 
In a previous paper, focusing on the wound edge, our laboratory reported that RPE cells in the 
RLEC enter the cell cycle with almost the same time course as that observed in vivo (Yoshikawa et 
al., 2012). Together with a subsequent paper (Mizuno et al., 2012), our laboratory discovered that 
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cell cycle re-entry of RPE cells in the RLEC requires a MEK1/2-ERK1/2-mediated intracellular 
signaling pathway, whose activity rises transiently within 30 min after retinectomy both in vivo and 
in vitro. Consequently, our laboratory proposed this as the putative pathway for the cell cycle 
re-entry of RPE cells. In this study, based on previous studies, the signaling pathways triggering 
Pax6 expression with a focus on the relationship with cell cycle re-entry were investigated. 
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2. Materials and Methods 
 
 
2.1 Identification of the Pax6 variant expressed in the eyeballs of the adult newt 
2.1.1 Animals 
Japanese fire belly newts, Cynops pyrrhogaster, were purchased from local suppliers (Ouchi 
Kazuo Seibutsu Kyozai, Saitama, Japan/Aqua Grace, Yokohama, Japan). The newt for this 
experiment was originally captured from Chiba or Okayama prefecture, Japan. The animals had been 
reared in containers into which water had been poured to a depth of 5 cm, and placed at 18°C under 
natural light. They were fed daily with frozen mosquito larvae (Akamushi; Kyorin, Himegi, Japan), 
and the containers were kept clean at all times. To select those newts which had completely matured 
into adults, individuals of sufficient size (total body-length: 9–11 cm) were used. Before surgical 
operation or sacrifice, newts were anesthetized for 2 h with FA100 (1:1000; 
4-allyl-2-methoexyphenol; DS Pharma Animal Health, Osaka, Japan) in the dark. All experiments 
were carried out in accordance with the guidelines approved by the University of Tsukuba Animal 
Use and Care Committee. 
 
2.1.2. Transcriptome data 
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To search unknown Pax6 isoforms expressed in the eyes of the adult newt, a de novo assembled 
transcriptome database (IMORI, http://antler.is.utsunomiya-u.ac.jp/imori/) from the eyes at 0-14 
days after removal of both the neural retina and the lens was used. This database was created in our 
laboratory using a next-generation sequencer (Nakamura et al., 2014). At that time, three algorithms, 
Trinity, Trans-ABySS and Velvet-Oases, were applied during database assembly (Nakamura et al., 
2014). Three assembled database was integrated into one as a sequence database, and blastn (version 
v2.2.26+, NCBI) was carried out using a known Pax6 (Accession #: D88741) as the query sequence. 
The contigs which connected to unknown Pax6 sequences were selected from the blastn results. An 
ensuing blastn, which used only unknown regions of Pax6 as the query sequence, was performed. 
Until a newly unknown sequence was not provided, the search was repeated. Finally, some 
candidates of new Pax6 classes were derived to connect them. 
 
2.1.3. Design of primer sets 
The candidates of new Pax6 classes expected in silico had unique sequences upstream of the 
PD-coding region, including 5ʹ UTR. To confirm the existence of new Pax6 isoforms in the eyes of 
adult newts and to decide their sequence information, forward primers located in the unique 
sequences of the 5ʹ UTR that could distinguish the different classes of Pax6, were designed. 
Furthermore, to design reverse primers located in known and common sequences of the 3ʹ UTR, the 
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primer sets were configured so as to amplify the ORF. 
 
2.1.4. Sample preparation from parts of the normal eyeball 
After the eyeball was excised, it was opened up along the equator in RNase-free PBS. The 
operation took place in this solution by manipulating fine forceps and scissors under a dissecting 
microscope. The ciliary marginal zone (CMZ), iris, lens, cornea limbus (CL) and cornea were 
isolated from the anterior half of the eye (Figure 3). NR and RPE cells, together with the choroid 
tissues (RPE-choroid) and sclera, were isolated from the posterior half of the eye (Figure 3). Using a 
thin needle that can peel each tissue, sclera and NR were removed to reveal the RPE-choroid. It is 
difficult to remove RPE cells from the basal membrane mechanically. The separation of RPE cells 
from RPE-choroid tissue was performed in a solution containing protease and chelate. After as many 
blood cells in the choroid were removed as possible by shaking the samples in the dish, samples 
were transferred into elastase (1 mg/ml; Porcine pancreas; Ref: 11027891001; Roche Diagnostics 
Japan, Tokyo, Japan) in EDTA solution (in mM: 115 NaCl, 3.7 KCl, 10 EGTA, 18 D-glucose, 10 
HEPES, and 0.001% phenol red, pH 7.5 adjusted with 0.3N NaOH) and incubated for 90 min at 
28°C. Subsequently the tissue samples were rinsed with RNase-free PBS several times and then RPE 
cells were separated by a current which was created by pipetting the tissues with a 3.5 ml transfer 
pipette (Sarsted, D-51588 Nümbrecht, Germany). The suspension was transferred to 1% 
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agarose-coated 35-mm plastic dishes (08-772A, Thermo Fisher Scientific, Waltham, MA, USA). 
After verifying that RPE cells were not contaminated by other tissues, they were used as the RPE 
sample. The residual tissue, which was confirmed to have completely separated RPE cells, was used 
as the colloid sample. 
 
2.1.5. Molecular cloning 
Total RNA was extracted from whole/tissues/cells collected from 3-5 eyeballs using a total RNA 
isolation kit (5185-6000, Agilent Technologies, Santa Clara, CA, USA), and template cDNAs were 
conventionally constructed using SuperScript II Reverse Transcriptase (18064-014, Thermo Fisher 
Scientific). Although the commercial kit was basically used according to the manufacturer’s 
instructions, the reaction time of reverse transcriptase was extended to 90 min. PCR was performed 
using KOD FX (KFX-101, Toyobo, Tokyo, Japan). The confirmed PCR amplification product was 
cloned. To prevent PCR errors, the number of cycles was minimized to 25. The PCR products were 
electrophoresed by agarose gel (Solana Agarose STANDARD 01, Rikaken, Nagoya, Japan) 
electrophoresis and the bands of expected size were cut out. 
After purifying DNA using a Geneclean Spin Kit (111101200, MP Biomedicals, Santa Ana, CA, 
USA) and having added adenine to the blunt 3ʹ end with advantage 2 (639206, Takara Bio, Otsu, 
Japan), TA was cloned with the TOPO TA Cloning Kit (K4560-01, Thermo Fisher Scientific). DNA 
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sequencing was carried out using ABI Prism 3130 (Thermo Fisher Scientific). For each class of Pax6, 
the nucleotide sequence of the longest variant was deposited in DDBJ/GenBank (Accession #: Pax6 
v2, LC002642; Pax6 v3, 28 LC002643; Pax6 v4, LC002644). 
 
 2.1.6. Antibodies 
Chicken polyclonal anti-Pax6 antibody PA1-801 (1:1,000; Thermo Fisher Scientific) and rabbit 
polyclonal anti-Pax6 antibody PRB-278P (1:1,000; Covance, Princeton, NJ, USA) were used as the 
primary antibodies. PA1-801, which can recognize a sequence (REEKLRNQRRQASNTPSHI) 
neighboring the 3ʹ end of HD in the newt, was applied to immunoblotting. This epitope is present in 
all classes of Pax6 variants but this antibody was inadequate for immunohistochemistry. Therefore, 
PRB-278P was applied to immunohistochemistry. This antibody has high reactivity and recognizes 
the C-terminal (QVPGSEPDLSQYWPRIQ) of LL and SL forms of Pax6 and the –L form of 
paired-less Pax6. Biotinylated goat anti-chicken IgG antibody (1:500; BA-9010, Vector Laboratories, 
Burlingame, CA, USA) and anti-rabbit IgG antibody (1:500; BA-1000, Vector Laboratories) were 
used as the secondary antibodies. The negative controls were obtained by omitting the primary 
antibodies. 
 
2.1.7. Immunohistochemistry 
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Normal eyeballs were fixed in 2% paraformaldehyde / 0.2% picric acid in PBS (pH 7.5) for 5-6 h 
at 4°C and cryosectioned at a thickness of ~20 μm after washing away the fixative solution. Tissue 
sections were rinsed thoroughly (PBS, 1% TritonX-100 in PBS, PBS, 15 min each rinse), treated 
with 3.3% H2O2 in methanol for 20 min, washed thoroughly, incubated in a blocking solution [3% 
normal goat serum (S-1000, Vector Laboratories) / 1% TritonX-100 in PBS] containing Avidin D 
(1:50; Avidin/Biotin Blocking kit, SP-2001, Vector Laboratories) for 2 h, washed in PBS twice, and 
then incubated in the primary antibody diluted with the blocking solution containing Biotin (1:50; 
Avidin/Biotin Blocking kit) for 72 h at 4°C. After washing thoroughly, the samples were incubated 
in the biotinylated secondary antibody diluted with the blocking solution for 4 h at room temperature, 
washed thoroughly, incubated in a mixture of Avidin and Biotin Complex (Vectastain ABC Elite kit, 
PK-6100, Vector Laboratories) for 2 h, washed thoroughly, and then incubated in a DAB solution 
(DAB substrate kit, SK-4100; Vector Laboratories) for 6 min. After the samples were washed, 
melanin pigments in the tissues were bleached, and the nuclei of RPE cells were stained with DAPI 
(1:50,000; D1306, Thermo Fisher Scientific). 
Images of tissues were acquired using a CCD camera system [C4742-95 ORCA-ER system 
(Hamamatsu Photonics, Hamamatsu, Japan) or a DP73 system (Olympus, Tokyo, Japan)]. Figures 
were prepared using Photoshop Extended CS5 (Adobe, San Jose, CA, USA). 
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2.1.8. Discrimination of the classes of Pax6 variants in normal eyes 
PCR was performed using KOD FX and the primer sets distinguished the new and known classes 
of Pax6 against several cDNAs from each ocular part of the eye. The number of cycles was 
increased compare with the cloning step (PCR conditions, see Table 2). To evaluate the integrity of 
cDNAs, the expression of EF1-α (Accession #: AB005588, sense, 5′-gacctttgcccccagtaacgtaaccac-3′; 
antisense, 5′-actgggtgttgctggcgctacttcttg-3′; 573-bp) was confirmed. An MJ Mini Gradient Thermal 
Cycler (PTC-1148, Bio-Rad, Hercules, CA, USA) was routinely used. Exceptionally, to examine 
Pax6 v2 transcripts, a Takara PCR Thermal Cycler 1 MP (TP3000, Takara, Otsu, Japan) was also 
used. 
 
2.1.9. Immunoblotting 
Sample tissues were prepared from five anterior halves of eyeballs after removing the lens and 
adding 75 µl of lysis buffer [25 mM Tris-HCl (pH = 7.5), 150 mM NaCl, 1 mM EDTA-2Na, 1% 
Igepal CA-630 (56741, Sigma-Aldrich, St. Louis, MO, USA), 1% protease inhibitor cocktail (P8340, 
Sigma-Aldrich), 1% sodium deoxycholate (190-08313, Wako Pure Chemicals Industries, Ltd., Osaka, 
Japan), and 0.1% SDS (191-07145, Wako)] chilled on ice. Samples in the sample tube were frozen in 
liquid nitrogen and sonicated in chilled water for 5 min. The frozen sample was gradually dissolved. 
After this step was repeated once more, the suspension was centrifuged at 7000 g for 10 min by a 
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cooled centrifuge at 4°C. The supernatant was mixed with the same amount of SDS sample buffer 
[0.5 M Tris-HCl (pH = 6.8), 10% (w/v) SDS, 10% 2-mercaptoethanol (M3148, Sigma-Aldrich), 20% 
glycerol, 0.5% (w/v) bromophenol blue (021-02911, Wako)] and immediately heated for 5 min in a 
water bath at 98°C. 
Protein samples (µl/lane) were separated on a 10% Mini-PROTEAN TGX Precast Gel (456-1033, 
Bio-Rad, Hercules, CA, USA) by SDS-PAGE and electrophoretically transferred onto an 
Immun-Blot PVDF membrane (1620174, Bio-Rad) using a Mini transblot cell (1703930JA, 
Bio-Rad). 
The blots were incubated in blocking solution [5% non-fat skimmed milk (198-10605, Wako) in 
TBST [100 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.05% Tween20]] containing Avidin D (1:50; 
Avidin/Biotin Blocking kit) for 1 h, rinsed with TBST twice, and then incubated overnight at 4°C in 
the primary antibody diluted with the staining system [Can Get Signal (NKB-101T, Toyobo)] 
containing Biotin (1:50; Avidin/Biotin Blocking kit). After washing three times in TBST for 15 min 
each wash, the blots were incubated in biotinylated secondary antibody diluted with the staining 
system [Can Get Signal] for 90 min at room temperature, washed three times in TBST, incubated in 
a mixture of Avidin and Biotin Complex (Vectastain ABC Elite kit) for 90 min, washed six times in 
TBST, and then incubated in a DAB solution (DAB substrate kit) until the bands were visualized. 
The negative control was obtained by omitting the primary antibody. 
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2.2. RPE cells newly express Pax6 v1 and v2 variants upon retinectomy 
2.2.1 Retinectomy 
To induce retinal regeneration, living newts were held in an operating chamber. The dorsal half of 
the left eye was cut open along the position slightly below the boundary between the cornea and 
sclera using a blade and fine scissors. While sterile saline solution (in mM: NaCl, 115; KCl, 3.7; 
CaCl2, 3; MgCl2, 1; D-glucose, 18; HEPES, 5; pH 7.5 adjusted with 0.3N NaOH) was infused into 
the vitreous chamber through the slit by an injection needle (27Gx3/40, NN-2719S, Terumo, Tokyo, 
Japan) which was connected to a syringe (1 ml, SS-01T, Terumo) via a filter cassette (0.20 mm pore 
size, Cellulose acetate, DISMIC-25CS, ADVANTEC, Japan), both the neural retina and lens were 
carefully removed by same needle and forceps. After operation, the slit was carefully placed back to 
its original position. The retinectomized animals were maintained in a moist container at 22°C (the 
day-night cycle was 12 h:12 h). The container was kept clean and the animals were not fed to control 
the speed of regeneration. 
 
2.2.2. Discrimination of the classes of Pax6 variants in RPESCs 
When almost all RPE cells reached Stage E-1 at 10 days after the operation (Chiba 2006; Islam et 
al., 2014), the eyeball was extracted. In the same timing as normal eyeballs, five tissues were 
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collected. These were treated more carefully because the connection between the regenerating cells 
and the basal membrane was weak. The eyeball was opened up along the equator, and the posterior 
side of the wound created during retinectomy, as well as the part which not affected by it, were 
collected. The existence of RPESCs was confirmed inside each hemisphere and separated, together 
with the colloid, from the sclera. Using the RPESCs with a colloid (RPESCs-colloid), template 
cDNAs were constructed using the same procedure described in 2.1.5. 
Exceptionally, template cDNAs were prepared from isolated RPESCs as follows. 
Cells on the basal membrane were isolated by elastase in EDTA solution as described in section 
2.1.4. The isolated cell suspension was transferred to 1% agarose-coated 35-mm plastic dishes 
placed on ice. 
To avoid contamination of the basement membrane and colloid tissue that became fragile during 
regeneration, solitary RPE cells or RPE-derived cells were identified by their morphological 
characteristics (Figure 13). Then 100 cells were selected and placed into a PCR tube (No T-02F, Ina 
Optica, Osaka, Japan) using a microtip (703Y, Ina Optika) attached to a micropipette (set at 0.5 ml; 
Pipetman P20; Gilson, WI 53562-0027, USA) under a dissecting microscope. The cells were 
accumulated at the bottom of the tube after centrifugation for 1 min at 3,000 g. Because the amount 
of mRNA in a single cell is small, two-step pre-amplification of the cDNA was carried out. Total 
RNA was obtained and cDNA was constructed using TaKaRa CellAmp Whole Transcriptome 
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Amplification Kits (Real Time) Ver.2 (3730; Takara). In this step, the resulting cDNAs were 
pre-amplified non-selectively by PCR (21 cycles). Furthermore, cDNAs were pre-amplified by PCR 
(65 cycles) using KOD FX with the class-specific primer sets. PCR products were separated by 
agarose gel electrophoresis, and those corresponding to the size of Pax6 variants were excised and 
purified using a Geneclean Spin Kit. Pre-amplified cDNAs were prepared for all classes of Pax6, 
and used as the templates. 
Discrimination of the classes of Pax6 variant was performed against cDNA from RPESCs-colloid 
and isolated RPESCs in the same way as indicated in section 2.1.8. 
 
2.3. Estimation of the signal pathway causing the reprogramming of RPE cells 
2.3.1. Preparation and incubation of RLECs 
After the eyeball was excised, the muscle which was attached to the sclera, was carefully removed. 
It was sterilized twice for 20 sec by 70% ethanol, placed cornea side up on a membrane filter 
(HAWP 013 00, Millipore, Billerica, MA, USA), and cut along the equator. The anterior half was 
carefully removed and the posterior half (eye-cup) was soaked in PBS for 20-30 min to create a 
loose connection between NR and RPE. Then NR was peeled off by a needle and forceps to create a 
RLEC, and the optic nerve was cut out. An RLEC of 0 DIV was used for analyses. The other RLEC 
was incubated in 80% L-15 medium (41300-039, Thermo Fisher Scientific) containing 2% 
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penicillin-streptomycin liquid (15140-122, Thermo Fisher Scientific) at 25°C for up to 10 days. The 
medium was refreshed on day-5 of incubation (Figure 18). 
The following factors were added to culture medium. MEK1/2-specific inhibitor U0126 (V1121; 
Promega, Fitchburg, WI, USA), which was dissolved in DMSO (D2650; Sigma-Aldrich) at 2 mM 
immediately before use, was administered at a final concentration of 5 μM from the time point at 
which the eye-cup was soaked in PBS and the culture medium. Heparin, sodium salt (081-00136, 
Wako) was added to the medium at a concentration of 7.5 μg/ml from the beginning of incubation. 
The newt FGF2 (see Susaki and Chiba, 2007) was tested by adding it to the heparin-containing 
medium at a concentration of 50 ng/ml. 
When the medium was replaced, fresh factors were added. 
 
2.3.2. PCR analysis 
RLECs, which were incubated for 10 days or simply removed from normal eyeballs, were 
transferred to RNase-free PBS. RPE cells with colloid tissue were peeled off from the remainder of 
RLECs. In the same manner as described in section 2.2.2., sample collection, cDNA synthesis and 
discrimination of the classes of Pax6 variant were carried out. 
 
2.3.3. Antibodies 
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Rabbit polyclonal anti-Pax6 antibody PRB-278P (1:500; Covance) and mouse monoclonal 
anti-RPE65 antibody (1:500; MAB5428, Millipore) were used as the primary antibodies. 
Biotinylated goat anti-rabbit IgG antibody (1:500) and Alexa-488-comjugated goat anti-mouse IgG 
antibody (1:500; A-11008, Thermo Fisher Scientific) were used as the secondary antibodies. To 
confirm that there was no nonspecific adsorption of the primary antibody, the anti-Pax6 antibody in 
which epitope was blocked in the target amino acid sequence itself was used as the negative control. 
PRB-278P was pre-adsorbed with a synthetic peptide (QVPGSEPDLSQYWPRIQ) corresponding to 
the newt Pax6 to make the negative control. The antibody to which the peptide (50 μg/ml) was added 
was placed overnight at 4°C before use. When the negative control was used, the test antibody was 
also dispensed to maintain the same conditions. 
 
2.3.4. Immunohistochemistry 
RLECs attached to the sclera, as well as the membrane used in culture, were fixed in 4% 
paraformaldehyde in PBS for 2.5 h at 4°C. The fixative solution was washed off. The tissue sections 
were sliced to a thickness of ~20 μm and stained as in section 2.1.7. When double staining was 
performed, two antibodies were simultaneously added to the solution. 
For whole-mount staining, RLEC preparations were rinsed thoroughly (PBS, 1% TritonX-100 in 
PBS, PBS, 15 min each), treated with 3.3% H2O2 in methanol for 20 min on ice, washed thoroughly, 
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incubated in a blocking solution [3% normal goat serum (S-1000, Vector Laboratories) / 1 % 
TritonX-100 in PBS] containing Avidin D (1:50; Avidin/Biotin Blocking kit) for 2 h, washed in PBS 
twice, and then incubated in the primary antibody diluted with blocking solution containing Biotin 
(1:50; Avidin/Biotin Blocking kit) for 72 h at 4°C. After washing thoroughly, the samples were 
incubated in the biotinylated secondary antibody diluted with the blocking solution for 4 h, washed 
thoroughly, incubated in a mixture of Avidin and Biotin Complex (Vectastain ABC Elite kit) for 2 h, 
washed thoroughly, and then incubated in a DAB solution (DAB substrate kit) for 6 min. The 
reaction was stopped by washing samples in distilled water. After the DAB solution was washed 
away, melanin pigments in the tissues were bleached by incubating in 15% H2O2 ⁄ 1.5% sodium 
azide (197-11091, Wako) in PBS overnight. After the bleaching solution was washed away, the 
nuclei of RPE cells were stained with DAPI (1:50,000; D1306, Thermo Fisher Scientific) for 6 h. 
The RPE-choroid tissue was separated from the sclera, placed RPE-side up on a glass slide, 
immersed into 90% glycerol in PBS and finally mounted under a cover slip. Bright-light and 
fluorescence images of tissues were acquired using the same CCD camera systems used in section 
2.1.7. 
 
2.3.5. Cell counting 
Total RPE cells in whole-mount preparations were identified and counted by observing their 
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characteristically flat and oval nucleus on the surface of the basement membrane in fluorescence 
field. Moreover, the amount of immunostaining that overlapped with nuclear staining was assessed 
in bright field as positive cells. In this study, total and Pax6-immunoreactive nuclei of RPE cells 
were counted in an area further than 50 μm from the peripheral margin of the RPE sheet, because 
non-specific staining along the margin, which was due to the primary antibody (rabbit IgG), was 
serious under the current conditions. 
 
2.3.6. Data analysis 
Data were presented as the mean ± SEM (n: the number of RLECs) from more than three 
independent rounds of experiments. Normality and non-parametric tests (Mann-Whitney’s U-test 
and Jonckheere-Terpstra test) were carried out to evaluate the statistical significance of the data, 
using Ekuseru-Toukei 2008 software (Social Survey Research Information, Tokyo, Japan). 
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3. Results 
 
 
3.1 Identification of Pax6 variants expressing in the eyeballs of adult newts 
3.1.1. Search for unknown Pax6 
To search for classes of unknown Pax6 expressed in the normal eye and regenerated retina of the 
adult newt, transcriptome data which our laboratory made in the past was used. This data was made 
using the total RNA obtained from the posterior half of the normal eye from which the retina and 
regenerating eyeball were removed at 0-14 days after retinectomy (Nakamura et al., 2014). After 
paired end sequencing was carried out by a next generation sequencer, the fragmentary sequence 
information was connected by assembly software. In this process, three algorithms were applied and 
three databases were produced because there is no consensus about the best de novo assembly 
software. In this study, three de novo assembled databases were integrated and used to search widely 
for unknown Pax6variants. 
By repeating the local blast analysis that used known Pax6 as the query sequence, three new 
classes of Pax6 transcripts were identified. In this study, these new Pax6 were named Pax6 
variant2~4 (v2~4) while the known Pax6 was named variant1 (v1). The characteristic common to the 
structure of all the new Pax6’s searched in silico was a unique sequence upstream of the PD-coding 
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region. Their unique 5ʹ regions are shown in Figure 4 and the full sequences are displayed in Figures 
5, 6 and 7. Pax6 v3 has a long unique sequence with partially homogeneity to the Pax6 regulatory 
region of other animals whereas the unique sequence of Pax6 v2 is short. These different unique 
sequences continue to share the same point where is just before the PD-coding region. On the other 
hand, in v4, the sequence extended to inside of the PD-coding region. This resulted in the lack of a 5′ 
part (127 bp) of the PD-coding region (i.e., a neighbouring sequence of the 5′ end of exon 5a) and 
the addition of a 92-bp extra sequence after the 3′ end of exon 5a. This class has an ATG start codon 
after the PD-coding region. Therefore, it is expected to encode paired-less forms of Pax6. Unlike 
these varieties of unique sequences, the sequence downstream of the PD-coding region has high 
homogeneity with known Pax6. 
Based on the above data, whether these Pax6 were expressed in the eyeballs of adult newts was 
checked. Primers were designed using sequences that are specific for each class of Pax6 and PCR 
was performed using a cDNA template which was reverse transcribed from mRNA extracted from 
whole adult newt eyeballs. Four kinds of Pax6 expected in silico, including three new classes, were 
detected. 
Splice variants in each class were also confirmed. Using RT-PCR, four variants of Pax6 v1 and v2 
(LL, SL, LS and SS) were confirmed. In contrast, only two variants (SL and SS) lacking 5a were 
identified in v3. In class v4, two variants probably encoding two paired-less forms (-L and -S) were 
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confirmed. Figure 8 shows the structure of each class, including splice variants. Thus, 12 variants of 
known or new Pax6 expressed in normal newt eyeballs with unique 5ʹ sequences were detected. 
 
3.1.2. Distribution of Pax6 variants in the adult newt eye 
Next, immunohistochemistry using antibody PRB-278P, which recognizes all classes of Pax6, was 
performed to confirm which parts of the normal eyeball express Pax6. The results of 
immunohistochemistry, which are shown in Figures 9 and 10, suggest that Pax6 is expressed in 
epithelial cells of the cornea, CL, lens and iris as well as in cells of the CMZ and in amacrine and 
ganglion cells in the NR, but not in the RPE, choroid or sclera. 
On the basis of this observation, tissue samples were isolated from each part of the eyeballs and 
the expression of Pax6 in them was examined by PCR with class-specific primer sets. Furthermore, 
splice variants were distinguished based on band size. PCR products were detected in most eye 
tissues except for the RPE, choroid and sclera (Figure 11). This is consistent with the 
immunohistochemical evidence. Previous studies reported that there is no Pax6 v1 in RPE cells 
(Chiba et al., 2006a; Islam et al., 2014; Nakamura et al., 2014). This experiment supports this claim 
and reveals that other classes of Pax6 are also not expressed in RPE cells. Table 1 summarizes the 
Pax6 variants that were identified in Figure 11. The NR had only four variants of Pax6 v1. In 
contrast, additional classes of Pax6 were confirmed in other parts. The CMZ and iris expressed both 
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Pax6 v1 and v2 but their expression patterns were different. In the CMZ, there were four variants for 
each class, but in the iris, only LS and SS were detected. The lens, CL and cornea expressed SL and 
SS of Pax6 v3 and -L and -S of Pax6 v4 as well as four variants of Pax6 v1 and v2, although PCR 
signals for Pax6 v3 in the lens and cornea were relatively weak (Figure11). 
To confirm the presence of Pax6 proteins, western blotting was carried out using anterior eye 
tissues where it is expected that all four classes of Pax6 exist. As indicated in Figure 12, two protein 
bands at around 50 kD, as well as bands at ~31.6 kD and ~26.4 kD, were recognized. The arrow in 
Figure 12 shows bands which were specifically labelled by Pax6 antibody while the arrowhead 
shows a non-specific band which appeared even when the primary antibody was omitted, i.e., in the 
control. The upper two bands are likely the merges of longer forms (LL) of Pax6 v1, v2 and v3. The 
bands were no longer able to separate because their structures and molecular weights were similar to 
each other. The lower bands corresponded to the -L and -S forms of Pax6 v4 because this is 
paired-less Pax6 with a small molecular weight. 
Taken together, these results suggest that Pax6 variants are expressed in many kinds of tissues in 
the eye in different combinations but not in intact RPE cells. 
 
3.2. RPE cells newly express Pax6 v1 and v2 variants upon retinectomy 
No class of Pax6 was expressed in intact RPE cells. However, past studies revealed that RPE cells 
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are reprogrammed into a unique multipotent state and newly express Pax6 in neural retina 
regeneration. Therefore, which Pax6 variants were expressed in RPESCs was analysed. 
At first, PCR was carried out with class-specific primer sets and RPESCs-choroid tissues collected 
from posterior halves of the eyeballs at 10 days after retinectomy. Figure 13 is an image of a 
collected sample that contains aggregates of RPESCs, which are RPE-derived cells which just 
entered Stage E-1. In this experiment, PCR conditions were changed and implemented for all 
subsequent analyses. Figure 14 shows two typical PCR results. On the left, product bands 
corresponding to LL, SL, LS and SS of Pax6 v1, and to LL of Pax6 v2, were recognized. On the 
right, three other variants of Pax6 v2 were also detected in the same template when the annealing 
temperature of PCR was changed. All four variants of Pax6 v1 and v2 were identified, but no 
variants for Pax6 v3 or v4 were detected (Figure 15). On the other hand, no product bands were 
detected in the choroid tissues after RPE-derived cells had been removed (Figure 16). The same 
result was obtained in three independent rounds of experiments. 
 For further confirmation, RPESCs were isolated from the choroid by protease and a chelator. While 
confirming cell shape under a microscope, RPESCs were selected from pieces of other pigmented 
organized structures (Figure 13). Single-cell PCR with 100 isolated RPESCs was then attempted, 
and expression of the same classes of Pax6 was confirmed and compared with RPESCs-choroid 
tissue (Figure 17). However, under this condition, variants of detectable transcripts were limited to 
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SS for Pax6 v1 and SL for Pax6 v2. When PCR conditions were changed, additional variants were 
not detected. This result may reflect a difference in the stage of regeneration between both samples. 
A recent study indicated that it is possible for individual RPE cells to be reprogramed at a slightly 
different timing in the E-1 stage (Islam et al., 2014). In isolated RPESCs, uniform cells that had just 
begun reprogramming, were selected. Of note, the RPESCs-choroid tissue contained cells with an 
advanced stage of regeneration. 
Taken together, these results suggest that transcript variants, possibly LL, LS, SL and SS, of two 
classes of Pax6 (i.e., v1 and v2) are expressed in RPE-derived cells in Stage E-1. 
 
3.3. Estimate of the signal pathway which causes the reprogramming of RPE cells 
3.3.1. RPE cells also express Pax6 v1 and v2 variants in RLECs 
The signals that may have caused the reprogramming of RPE cells were estimated by using Pax6 
expression as the marker of this phenomenon. Therefore, in this study, the RLEC system that was 
established to check the response of the RPE cells in our laboratory was used. Figure 18 shows the 
procedure of how to make the RLEC system. The newt eyeball was extracted and sterilized. The 
anterior hemisphere (the lens side) was cut off. The exposed NR was removed from the remaining 
posterior half of the eyeball in PBS and the RLEC was incubated in 80% L-15 medium at 25°C. 
L-15 medium is minimal essential medium consisting of amino acids, vitamins, inorganic salts, 
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galactose and sodium pyruvate. Since L-15 medium does not include any growth factors, it was 
suitable for this experiment to apply any factor. 
At first, it was confirmed whether this system could be adapted to the analysis of Pax6 expression. 
The existence of the target protein was confirmed by using anti-Pax6 antibody, which recognized all 
variants of Pax6. The results of whole-mount staining are shown in Figure 19. Images of the RPE 
cell layer represent a top view. New Pax6 antibody-positive cells were observed in the RLEC system 
after incubation for 10 days. The right-hand panel represents the negative control on day-10. The 
antibody preadsorbed with the peptide which was specific for the epitope was used as the negative 
control to completely remove non-specific staining of the primary antibody as well as the secondary 
antibody. Pax6-immunoreactivity in RPE cells was confirmed by double staining of a section of a 
day-10 RLEC with RPE65 antibody (Figure 20). Images of the RPE cell layer were viewed from the 
side. RPE cells were identified by RPE65-immunofluorescence (Chiba et al., 2006a). The nuclei of 
RPE cells were labelled with Pax6 antibody (arrows). Horizontal bars indicate the thickness of the 
RPE layer, and asterisks indicate small nuclei in the choroid, which displayed nonspecific staining as 
well as autofluorescence under these conditions. These two immunohistochemical results of RLECs 
revealed that Pax6 protein exists in several nuclei of RPE cells on day-10. 
PCR analyses were then carried out with RPE-choroid tissues collected from RLECs immediately 
after the NR was removed (day-0; d0) and with RLECs after 10 days of incubation (day-10; d10) in 
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vitro (Figure 21). No Pax6 variant was detected on day-0 and all four variants of Pax6 v1 and v2 
were newly expressed by day-10 while Pax6 v3 and v4 variants were not. These results were 
consistent with the in vivo results. 
These results indicate that RPE cells incubated in the RLEC system express Pax6 as the in vivo 
state. In particular, because variants expressed in RLEC and in vivo are common, regulation is 
suggest to be equal, which expands the applicability of the RLEC system. Thus, this system was 
subsequently used for the analysis of Pax6 expression signals. 
 
3.3.2. RPE cells expressing Pax6 versus RPE cells entering cell-cycle 
Interestingly, even though no external factors were added to cultures in the period of incubation, 
Pax6 was expressed in RLEC RPE cells. RLEC was incubated in minimal medium (Figure 19). 
Furthermore, the conditions of RPE cells in which Pax6 was expressed were different from those of 
RPE cells entering the cell cycle (Yoshikawa et al., 2012). Figure 22 indicates the ratio of 
Pax6-imunoreactive (Pax6+) nuclei in the RPE sheet derived from RLEC which was incubated 
without any factors. Pax6+ nuclei appeared within 5 days and increased significantly between 5 and 
10 days. The Pax6+ nuclei were distributed uniformly (Figure 19). The number of nuclei was 
counted in the area farther than 50 μm from the peripheral margin of the RPE to avoid non-specific 
staining. The timing of Pax6 expression differed from the cell-cycle re-entry observed from day-5 to 
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10 (Yoshikawa et al., 2012). In addition, Pax6-positive cells and cells entering the cell cycle also 
showed a variable distribution pattern (Figure 23). Pax6 was expressed uniformly in RLEC, but after 
entering the cell cycle, expression concentrated in the area near the Edge of RLEC (Yoshikawa et al., 
2012). It is possible that Pax6 expression and cell cycle re-entry are independently controlled in the 
RLEC system. 
 
3.3.3. Pax6 expression in RPE cells is not affected by a MEK1/2 inhibitor U0126 
As described in the introduction, our laboratory discovered that the MEK1/2-ERK1/2 intracellular 
signaling cascade, which was activated within 30 min after retinectomy, is necessary for the first cell 
cycle entry of RPE cells in the RLEC system (Mizuno et al., 2012). Therefore, the relationship of the 
MEK1/2-ERK1/2 signaling cascade and Pax6 expression in RPE cells was examined. 
RLECs were incubated in the presence of an MEK1/2 inhibitor U0126 at a concentration of 5 μM, 
which can inhibit up to ~50% of the initial activation of ERK1/2 and decrease the number of BrdU+ 
cells by 10 days by as much as ~25% (Yoshikawa et al., 2012). However, this treatment did not 
affect the number of Pax6+ RPE cells at 5 days compared to the solvent (0.25% DMSO) only 
(Figure 24). This result suggests that Pax6 can be expressed without the participation of the 
MEK1/2-ERK1/2 signaling cascade and that Pax6 expression in RPE cells may be independent of 
their cell cycle re-entry. 
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3.3.4 Heparin promotes the expression of Pax6 with the help of the MEK1/2-mediated 
pathway 
Pax6 expression and cell cycle re-entry of RPE cells take place in the same period after 
retinectomy in vivo (Islam et al., 2014). An endogenous factor mediating these independent 
phenomena exists in vivo, but is exhausted in vitro was hypothesized. 
Heparin, a glycosaminoglycan that is ubiquitously distributed in the body, and is known to bind 
various soluble factors and support their actions on receptors as well as protect these factors against 
degradation, served as a supplement. In fact, in the newt, heparin promotes the cell cycle re-entry of 
RPE cells in the RLEC system through a pathway that influences the area downstream of the 
MEK1/2-ERK1/2 signaling module (Yoshikawa et al., 2012). Therefore, heparin was added as an 
endogenous factor to activate RLEC. 
Interestingly, when the RLEC was incubated for 5 days in the presence of heparin (7.5 μg/ml), the 
number of Pax6+ RPE cells tended to increase (Figure 25). Next the effects of U0126 (5 μM) on the 
promotion of Pax6 expression by heparin were examined (Figure 25). In this condition U0126 was 
tested. The number of Pax6+ RPE cells at 5 days after incubation had decreased significantly. These 
results suggest that heparin promotes Pax6 expression with the help of a MEK1/2-mediated pathway. 
Finally, FGF2 was tested. FGF2 is a heparin-associated growth factor that is reportedly related to 
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regeneration. FGF2 is known to up-regulate Pax6 expression through the MEK-ERK pathway in 
chick embryonic RPE cells (Luz-Madrigal et al., 2014; Spence et al., 2007). However, 
administration of 50 ng/ml FGF2, a concentration used in previous experiments using RLEC (Susaki 
and Chiba, 2007), did not influence the effect of heparin on Pax6 expression in RPE cells after 10 
days of incubation (Figure 26). 
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4. Discussion 
 
 
4.1. Several kinds of Pax6 variants 
To date, a wide variety of Pax6 transcripts has been detected in many vertebrates, from fish to 
mammals. In addition, it is known that transcriptional initiation sites on the locus and 
post-transcriptional and post-translational modifications that derive various isoforms are 
spatiotemporally regulated in normal development and adult neurogenesis (Bandah et al., 2007; 
Gorlov and Saunders, 2002; Kammandel et al., 1999; Kim et al., 2008; Lakowski et al., 2007; 
Mizuno et al., 1997; Shaham et al., 2012; Walther and Gruss, 1991; Zhang et al., 2010). In the newt 
C. pyrrhogaster, a Pax6 gene corresponding to Small eye (Sey) Pax6 has been reported (Islam et al., 
2014; Mizuno et al., 1997). In this study, new three classes of Pax6 were discovered. The sequence 
of the conserved region of these Pax6 is extremely similar. These sequence similarities suggest that 
these different classes of transcripts originate from the same locus. On the other hand, each class of 
Pax6 has a unique sequence upstream of the PD-coding region, including the 5′ UTR (Figure 4), 
suggesting differences in transcriptional regulation among these classes. 
These classes of Pax6 are expressed in the intact eye tissues of the adult newt in different 
combinations, except in the RPE, choroid and sclera, as shown in this thesis. These findings may 
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provide suitable ground work for a study on the regulation and roles of the different classes of Pax6 
variants in the newt. In this study, sequence information of the Pax6 variants was indispensable for 
determining the class of Pax6 expressed in RPE cells after retinectomy. 
 
4.2. RPESCs and CMZ express common Pax6 variants 
As described in the introduction, after retinectomy, adult newt RPE cells undergo a loss of their 
membrane attachment, forming cell aggregates in 10 days (Stage E-1 [4]). During this process, RPE 
cells are reprogrammed into a unique multipotent state with newly expressed c-Myc, Klf4, Sox2, Mitf 
and Pax6, while preserving their original characteristics (Islam et al., 2014). In this study, the class 
of Pax6 expressed in such RPE-derived cells in Stage E-1 was determined, namely Pax6 v1 and v2, 
both of which give rise to four splice variants LL, SL, LS and SS. It is still uncertain whether Pax6 
works as a reprogramming factor in this system. However, it is possible that the expression of Pax6 
in RPE-derived cells represents the reprogramming of RPE cells. 
These should have the potency to form either the pro-NR or pro-RPE layer, as in cells in the early 
optic vesicle which also express c-Myc, Klf4, Sox2, Mitf and Pax6 (Islam et al., 2014). 
In early eye development, Pax6 and Mitf are known to be involved in fate decision of cells in the 
optic vesicle to form either pro-NR or pro-RPE cells as the optic vesicle invaginates to form the 
optic cup (Fuhrmann et al., 2014; Martínez-Morales et al., 2004). Up-regulation of Pax6 or 
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down-regulation of Mitf biases the fate of cells toward the retinal stem/progenitor cells (Azuma et al., 
2005; Fuhrmann et al., 2014; Nguyen and Arnheiter, 2000). 
In the regeneration of the adult newt retina, up-regulation of Pax6 was observed in a population of 
RPE-derived cells that formed the pro-NR layer in the next stage (Islam et al., 2014). Intriguingly, in 
this study, the same set of Pax6 variants as those in RPE-derived cells are expressed in the CMZ 
where retinal stem/progenitor cells have been harbored since the embryonic stage was found. 
Therefore, as an analogy of early eye development, one hypothesis may be that these classes of Pax6 
variants express in the cells that have potency, producing neural retina. However, it is still uncertain 
whether Pax6 works as a reprogramming factor in this system. 
 
4.3. The signal which produces RPESCs 
In this study, Pax6 was examined as a marker of the reprogramed signal of RPE cells using the 
RLEC system. Interestingly, Pax6 expression did not require the administration of exogenous factors. 
Immunohistochemical analysis revealed that, in the absence of exogenously administered factors, 
Pax6+ cells in the RPE sheet appeared within 5 days after retinectomy and showed a gradual 
increase in number up to ~27 % (on average) of all RPE cells by 10 days, and that the Pax6+ cells on 
day-10 are distributed almost uniformly in the sheet. In addition, the appearance and increment of 
Pax6+ cells in the RPE sheet was not affected by U0126, a specific blocker against 
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MEK1/2-mediated signaling. In a previous study (Yoshikawa et al., 2012), it was shown that RPE 
cells enter the cell cycle even if factors were not provided in the RLEC system. Cell cycle re-entry 
and Pax6 expression were observed at the same time during Stage E1 in vivo regeneration. A 
previous study (Yoshikawa et al., 2012) indicated that the cell cycle re-entry of RPE cells in RLEC 
conditions is highly restricted to a zone of ~100 μm width along the peripheral margin of the RPE 
sheet, i.e., along the wound edge of the RLEC, an area that was defined as the ‘Edge’ . This event is 
obviously regulated by a MEK1/2-ERK1/2 module whose activity is transiently strengthened within 
30 min after retinectomy (Mizuno et al., 2012). Furthermore, the cells which reside in the central 
area of the RPE sheet, defined as the ‘Center’ in Yoshikawa et al. (2012), hardly enter the cell cycle, 
possibly through a mechanism equivalent to contact inhibition (Yoshikawa et al., 2012), although the 
activity of the MEK1/2-ERK1/2 module in the ‘Center’ is as elevated as in the ‘Edge’ (unpublished 
data provided by H. Yasumuro). 
 Taken together, Pax6+ cells and cells which re-enter the cell cycle on the same RPE sheet appear to 
show a different spatial distribution pattern and requirement of the activity of MEK1/2, suggesting 
that the expression of Pax6 in RPE cells after retinectomy can be triggered independently of their 
cell cycle re-entry. 
In the eye, Pax6 expression and cell cycle re-entry of RPE cells take place simultaneously (Islam 
et al., 2012). Other factors may dry up in the RLEC system but that mediate between these two 
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phenomena may be independently controlled in vivo. To reinforce this possibility, attention was paid 
to heparin, which activates the function of various growth factors. Heparin is the glycoprotein which 
is strongly negatively charged and combines with many growth factors such as FGFs, TGF-β and 
BMPs, to activate the function of these factors. Furthermore, evidence of the influence of the dosage 
of heparin in RPE cells entering the cell cycle was provided in past studies (Yoshikawa et al., 2012). 
Therefore, in this experiment, heparin was added as an endogenous factor in RLEC activation. 
Treatment of RLECs with heparin promoted Pax6 expression in RPE cells but this effect was 
inhibited by U0126. 
This result indicates that Pax6 expression promoted by heparin administration, but depends upon the 
activity of MEK1/2. In other words, heparin administration seems to coordinate the pathway for 
Pax6 expression with a pathway mediated by MEK1/2 which is involved in the cell cycle re-entry. 
This pathway is driven by heparin or by heparin-associated factors which might be released from 
tissues in the RLEC. 
Figure 27 indicates hypothetical pathways of molecular networks involved in the initial processes 
of retinal regeneration, including findings of cell cycle re-entry which were observed in parallel (red 
and green lines are aspects that became clear in this study). At least three intracellular signalling 
pathways in RPE cells after retinectomy were predicted: 
1) A pathway for Pax6 expression. This is the signal system which is MEK1/2-ERK1/2- and heparin- 
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independent. 
2) A MEK1/2-ERK1/2 pathway which is primarily involved in cell cycle re-entry. This is more likely 
to receive contact inhibition. 
3) A pathway driven by heparin or heparin-associated factors. This is located downstream of the 
MEK1/2-ERK1/2 pathway and mediates between it and Pax6 expression. 
 
4.4. Differences in RPE cells between humans and newts 
In humans, when the NR suffers a traumatic injury, RPE cells – as in the newt – start to lose their 
epithelial morphology while acquiring the ability to migrate and proliferate. However, unlike the 
newt, these finally withdraw the NR by contraction, leading to a loss of vision (Chiba, 2014). In this 
process of transformation, it has been suggested that RPE cells pass through a multipotent state and 
such multipotent RPE cells were named as human RPESCs. Human RPESCs are known to express 
Pax6 as well as c-Myc, Klf4, Sox2 and Mitf (Salero et al., 2012) as in newt RPESCs (Islam et al., 
2014) although the expression levels of Pax6 seem to vary depending on the RPE cell line from 
which the RPESCs are derived, or on the culture conditions (Salero et al., 2012). In the adult newt, 
Pax6 presumably plays important roles in retinal regeneration because its transcription is elaborately 
and dynamically regulated during retinal regeneration, as demonstrated in a previous study (Islam et 
al., 2014) and in the present findings. Therefore, knowledge of Pax6 regulation for retinal 
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regeneration of the adult newt, which was obtained in this study, would be a base to generate a 
neural retina in vitro or to regenerate an entire retina in vivo from RPE cells or RPESCs in humans. 
 
4.5. Conclusions and future directions 
In this thesis, the signaling pathways involved in the expression of Pax6 in adult newt RPE cells in 
a bid to identify the signal that is employed to trigger RPE cell reprogramming for retinal 
regeneration were investigated. As a result, the following aspects became clear: 
1) Pax6 v1 and v2 express in RPESCs; 
2) Pax6 expression is independent of entering the cell cycle; 
3) Pax6 expression and cell cycle entry are conjugated by heparin or heparin-associated factors. 
Future studies should perform proteomic analysis and identify factors that influence Pax6 
expression. In these experiments, Pax6 expression was independent of MEK1/2-ERK1/2, an aspect 
that requires further detailed verification. In addition, our laboratory developed a newt transgenic 
technique with greater efficiency (Casco-Robles et al., 2011; 2014). 
The functional analysis of Pax6 based on knowledge of its variants and the signal system that was 
employed in this study will deepen our understanding of newt retina regeneration.  
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Figure 1. Retinal regeneration in the adult newt Cynops pyrrhogaster by Chiba, 2014. 
(A-B) The NR is completely removed from the eye by a surgical operation ‘retinectomy’. (C) RPE 
cells are detached from each other as well as from the basement membrane, losing their epithelial 
characteristics (Stage ‘E-1’). (D) RPE-derived cells are then sorted into two populations which form 
the prospective-NR and -RPE layers. (E) These Cells start to proliferate and eventually regenerate 
new functional NR and RPE. 
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Figure 2. The structure of three typical Pax6 variants in vertebrates. 
PD:paired-domein. HD: homeo-domain. Canonical Pax6 is the most universal Pax6 variants. 
Pax6(5a) is made by inserts an additional exon 5a into canonical Pax6. Pax6⊿PD lacks the PD and 
is termed paired-less. 
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Figure 3. Position of the tissues used for sample preparation in the normal eyeball. 
Green: ciliary marginal zone (CMZ), Orange: iris, Purple: lens, Blue: cornea limbus (CL), Pink: 
cornea, Light blue: NR, Red: RPE cells, Deep blue: choroid. 
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Figure 4. Pax6 variants in the newt, C. pyrrhogaster. 
Their 5′ regions are shown here; yellow: start codon; green: sequence encoding the paired-domain 
(PD); Black underline: splicing region. 5′ untranslated region (5′UTR) was unique for each class of 
Pax6. The PD-coding sequence, except for that of Pax6 v3, had a splice region corresponding to ‘5a’ 
of the vertebrate Pax6. In Pax6 v4, however, the PD was not translated because the start codon 
appears after the PD-coding sequence. Pax6 v1 and v2 had four variants [Pax6 v1: LL (1,492 bp), SL 
(1,450 bp), LS (1,341 bp), SS (1,299 bp); Pax6 v2: LL (1,496 bp), SL (1,454 bp), LS (1,345 bp), SS 
(1,303 bp)], and Pax6 v3 and v4 had two variants [Pax6 v3: SL (2,328 bp), SS (2,177 bp); Pax6 v4: 
-L (2,001 bp), -S (1,850 bp)].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
 
 
Inami W., Islam M.R., Nakamura K., Yoshikawa T., Yasumuro H., Casco-Robles M.M., Toyama F., Maruo F., and 
Chiba C. (2016) Expression of two classes of Pax6 transcripts in reprogramming retinal pigment epithelium cells of 
the adult newt. Zool. Sci. 33:21-30 
 
Figure 5. Pax6 v2 transcripts in the newt C. pyrrhogaster. 
Yellow: start codon; grey: stop codon; green: sequence encoding the paired-domain (PD); blue: 
sequence encoding the homeo-domain (HD); Black underline: splicing region. 
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Figure 6. Pax6 v3 transcripts in the newt C. pyrrhogaster. 
Yellow: start codon; grey: stop codon; green: sequence encoding the paired-domain (PD); blue: 
sequence encoding the homeo-domain (HD); Black underline: splicing region. 
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Figure 7. Pax6 v4 transcripts in the newt C. pyrrhogaster. 
Yellow: start codon; grey: stop codon; green: sequence encoding the paired-domain (PD); blue: 
sequence encoding the homeo-domain (HD); Black underline: splicing region. 
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Figure 8. Pax6 protein isoforms were deduced from these splice variants. 
Pax6 v1: LL (49.9 kD), SL (48.4 kD), LS (47.3 kD), SS (45.8 kD); Pax6 v2: LL (48.3 kD), SL (46.8 
kD), LS (45.7 kD), SS (44.2 kD); Pax6 v3: SL (47.1 kD), SS (44.5 kD); Pax6 v4: -L (31.5 kD), -S 
(28.9 kD). PD:paired-domein. HD: homeo-domain. The unique amino acid sequences of Pax6 v1, v2 
and v3 exist before the PD. Pax6 v4 lacks the PD, and is classified as a paired-less type. 
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Figure 9. Expression patterns of Pax6 variants in the intact eyes of the adult newt. 
Immunohistochemistry was carried out to localize Pax6 in the cornea, lens and iris. 
The lower panel in each figure is a negative control with no primary antibody. In the cornea and lens, 
the region enclosed by a small box was enlarged in an inset panel and the nuclei with 
immunoreactivity are indicated by arrowheads. The abbreviations in the figures are as follows. (ce: 
corneal epithelium; le: lens epithelium; vi: ventral iris) Scale = 100 μm 
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Figure 10. Expression patterns of Pax6 variants in the intact eyes of the adult newt. 
Immunohistochemistry was carried out to localize Pax6 in the NR and RPE, choroid and 
sclera and CMZ and cornea limbus. 
The lower panel in each figure is a negative control with no primary antibody. In CMZ and cornea 
limbus, the region enclosed by a small box was enlarged in an inset panel and the nuclei with 
immunoreactivity are indicated by arrowheads. The abbreviations in the figures are as follows. (nr: 
neural retina; rpe: retinal pigment epithelium; onl: outer nuclear layer; inl: inner nuclear layer; gcl: 
ganglion cell layer; ch: choroid; sc: sclera; cl: cornea limbus; cmz: ciliary marginal zone) Scale = 
100 μm 
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Figure 11. PCR analysis with class-specific primer sets was carried out to determine the class 
of Pax6 expressed in each part of the eye. 
The transcript variants identified here are listed in Table 1. The eye tissues, except for the RPE, 
choroid and sclera, expressed different classes of Pax6 variants in different combinations. 
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Figure 12. Western blotting was carried out with anterior halves of the eyeballs to confirm the 
expression of Pax6 variants as proteins. 
Two protein bands around 50 kD and the bands at ~31.6 kD and ~26.4 kD, corresponding to longer 
forms of Pax6 v1, v2 and v3 (canonical type) and -L and -S forms of Pax6 v4 (paired-less type), 
were specifically labelled by Pax6 antibody (arrows). Arrowheads: non-specific band which 
appeared even when the primary antibody was omitted (Control). M: marker; AE: anterior eye. 
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Figure 13. The image of the sample collect. 
To avoid the contamination of the basement membrane and colloid tissue that became fragile in a 
regeneration process, solitary RPESCs were identified by their morphological characteristics 
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Figure 14. Pax6 v1 and v2 express in RPESCs upon retinectomy. 
RPE-derived cells were isolated together with the choroid tissues from eyeballs at 10 days after 
retinectomy (Stage E-1) and the expression of each class of Pax6 transcript was examined by PCR 
with class-specific primer sets. Left: All four transcript variants of Pax6 v1 and v2 were amplified.  
Right: For Pax6 v2, changing to PCR conditions allowed the detection of three other variants. S: 
sample; M: marker. 
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Figure 15. Pax6 v3 and v4 do not express in RPESCs upon retinectomy. 
RPE-derived cells were isolated together with the choroid tissues from eyeballs at 10 days after 
retinectomy (Stage E-1) and the expression of each class of Pax6 transcript was examined by PCR 
with class-specific primer sets. No transcripts were detected for Pax6 v3 and v4. S: sample; M: 
marker. 
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Figure 16. No product bands were detected in the choroid tissues after RPE-derived cells had 
been removed. 
The choroid tissues after RPE-derived cells had been removed were examined by PCR with 
class-specific primer sets. No transcripts were detected for Pax6 v1 and v2. S: sample; M: marker. 
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Figure 17. Single-cell PCR was carried out with 100 solitary RPESCs. 
RPE-derived cells, which still preserve their original morphological characteristics 10 days after 
retinectomy, i.e., RPESCs, were isolated from RPE-choroid tissues. Consistent with the results in 
figure 11, the only classes of Pax6 detected in RPESCs were Pax6 v1 and v2. However, under this 
condition, only one transcript variant was amplified for each class (SS for Pax6 v1 and SL for Pax6 
v2). S: sample; M: marker. 
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Figure 18. The procedure to make RLEC. 
The NR was removed from the posterior half (eye-cup) of the eyeball in PBS and the retina-less 
eye-cup (RLEC) was incubated in 80 % L-15 medium at 25 °C 
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Figure 19. Immunostaining of RPE cells in the RLECs was carried out with Pax6 antibody. 
Pax6-immunoreactivity was not detected on day-0 but was observed in the nuclei of RPE cells on 
day-10. The right-hand panel is a negative control for day-10 with a preadsorbed primary antibody. 
Scale = 200 μm. 
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Figure 20. Pax6-immunoreactivity in RPE cells was confirmed by double staining of a section 
of a day-10 RLEC with RPE65 antibody. 
Nuclei of RPE cells whose cytoplasm was stained with RPE65 antibody were labelled with Pax6 
antibody (arrows). Horizontal bars: thickness of the RPE layer. Asterisks: small nuclei in the choroid, 
which have nonspecific staining as well as autofluorescence under this condition. Scale = 40 μm. 
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Figure 21. PCR analysis was carried out with RPE-choroid tissues collected from the RLECs. 
PCR analysis was carried out with RPE-choroid tissues collected from the RLECs immediately after 
the NR was removed (day-0; d0) and with those after 10 days of incubation (day-10; d10). All four 
transcripts of Pax6 v1 and v2 were newly expressed after 10 days of incubation, but for Pax6 v3 and 
v4, no transcripts were detected, even in d10 samples. C: positive control with a cDNA sample 
prepared from the cornea. M: marker. 
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Figure 22. Pax6-immunoreactive (Pax6+) RPE cells in the RLEC gradually increased in 
number upon retinectomy. 
Pax6+ nuclei in the RPE appeared within 5 days and significantly increased between 5 and 10 days 
(Mann-Whitney U test, **: p < 0.00001). The Pax6+ nuclei were distributed uniformly. The number 
of nuclei was counted in the area farther than 50 μm from the peripheral margin of the RPE. Note 
that mitotic figures were hardly observed in RPE cells in this period. 
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Figure 23. Spatial distribution pattern of Pax6+ cells and cells which enter the cell cycle on the 
same RPE sheet. 
The nuclei of the RPE cells which are Pax6+ or enter the cell cycle are shown with black ovals in 
day-0,5,10. The range that confirmed staining at the RPE sheet is shown with large circle. 
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Figure 24. Relationship of Pax6 expression and MEK1/2-ERK1/2 signaling cascade. 
A MEK1/2-specific inhibitor, U0126 (5 μM), did not affect Pax6 expression in RPE cells after 5 
days of incubation compared to the solvent (0.25 % DMSO) only. 
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Figure 25. Relationship of Pax6 expression and heparin. 
Left: The ratio of Pax6+ RPE cells in the day-5 RLEC tended to increase in the presence of heparin 
(7.5 μg/ml). White asterisk: Jonckheere-Terpstra test, p=0.0421. Right: The effect of heparin on Pax6 
expression in RPE cells was significantly inhibited by U0126. Asterisk: Mann-Whitney’s U-test, 
p=0.0485. 
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Figure 26. Relationship of Pax6 expression and FGF2. 
Administration of FGF2 did not influence the effect of heparin on Pax6 expression in RPE cells after 
10 days of incubation. 
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Figure 27. Hypothetical pathways involved in cell cycle re-entry and Pax6 expression in RPE 
cells after retinectomy.  
The pathways illustrated in red and green were predicted in this study. After retinectomy, expression 
of the two classes of Pax6 (Pax6 v1 and v2) in RPE cells is triggered through a pathway separate 
from the MEK1/2-ERK1/2 pathway, which is involved in cell cycle re-entry (Yoshikawa et al., 
2012). The presence of heparin, or heparin-associated factors, seems to link two separate pathways 
(turn on), promoting Pax6 expression in a manner dependent upon MEK1/2 activity. Similar effects 
of heparin have been observed on cell cycle re-entry (Yoshikawa et al., 2012).  
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Table 1. Pax6 transcripts expressed in the adult newt eye. 
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Table 2. Pax6 class-specific primers and standard PCR conditions. 
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Sense primer Antisense primer
5′-3′ 5′-3′
94 °C, 2 min LL : 1,492
98 °C, 10 sec SL : 1,450
68 °C, 2 min LS : 1,341
68 °C, 2 min SS : 1,299
94 °C, 2 min LL : 1,496
98 °C, 10 sec SL : 1,454
63.3 °C, 30 sec LS : 1,345
68 °C, 2 min SS : 1,303
68 °C, 2 min
94 °C, 2 min SL : 2,328
98 °C, 10 sec SS : 2,177
68 °C, 3 min
68 °C, 3 min
94 °C, 2 min -L : 2,001
98 °C, 10 sec -S : 1,850
68 °C, 3 min
68 °C, 3 min
Class PCR conditions
Expected size
(bp)
atgcactttagctcacgaactcgcgaa gccttcaaattgtgcaaaggtcccttg
Pax6 v1
Pax6 v2
Pax6 v3
Pax6 v4
cgctggagcagttcaacatgcaga gccttcaaattgtgcaaaggtcccttg
ggaacatgattccatgcagcacagttc gccttcaaattgtgcaaaggtcccttg
cgagttcatggctcattagcagcacaa gccttcaaattgtgcaaaggtcccttg
50 cycles
50 cycles
50 cycles
50 cycles
